A comparison of islet autotransplantation with allotransplantation and factors elevating acute portal pressure in clinical islet transplantation

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 19, Issue 3, 2012, Pages 281-288

  Kawahara, Toshiyasu ^a   Kin, Tatsuya ^a   James Shapiro, A M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Clinical islet transplantation; Portal vein thrombosis; Portal venous pressure

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; CELL COUNT; CELL VOLUME; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PANCREAS ISLET TRANSPLANTATION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RETROSPECTIVE STUDY; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; INJECTIONS, INTRAVENOUS; ISLETS OF LANGERHANS TRANSPLANTATION; PORTAL PRESSURE; PORTAL VEIN; PORTOGRAPHY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; VENOUS THROMBOSIS;

EID: 84862544524     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0441-2     Document Type: Article

References (33)

1. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol. 2004;4(4):259-68.
2. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA. 2005;293(7):830-5.
3. Bellin MD, Kandaswamy R, Parkey J, Zhang HJ, Liu B, Ihm SH, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant. 2008;8(11): 2463-70.
4. Shapiro AMJ, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230-8.
5. Osama Gaber A, Chamsuddin A, Fraga D, Fisher J, Lo A. Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation. Transplantation. 2004;77(2): 309-11.
6. Owen RJT, Ryan EA, O'Kelly K, Lakey JRT, McCarthy MC, Paty BW, et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology. 2003;229(1):165-70.
7. Goss J, Soltes G, Goodpastor S, Barth M, Lam R, Brunicardi F, et al. Pancreatic islet transplantation: the radiographic approach. Transplantation. 2003;76(1):199-203.
8. Weimar B, Rauber K, Brendel M, Bretzel R, Rau W. Percuta-neous transhepatic catheterization of the portal vein: a combined CT- and fluoroscopy-guided technique. Cardiovasc Interv Radiol. 1999;22(4):342-4.
9. Sutherland D, Matas A, Najarian J. Pancreatic islet cell trans-plantation. Surg Clin N Am. 1978;58(2):365-82.
10. Blondet J, Carlson A, Kobayashi T, Jie T, Bellin M, Hering B, et al. The role of total pancreatectomy and islet autotrans-plantation for chronic pancreatitis. Surg Clin N Am. 2007; 87(6):1477-501.
11. Ahmad S, Lowy A, Wray C, D'Alessio D, Choe K, James L, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancre-atitis. J Am Coll Surg. 2005;201(5):680-7.
12. Sutherland D, Gruessner A, Carlson A, Blondet J, Balamurugan A, Reigstad K, et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Trans-plantation. 2008;86(12):1799-802.
13. Ryan E, Paty B, Senior P, Shapiro A. Risks and side effects of islet transplantation. Curr Diabetes Rep. 2004;4(4):304-9.
14. Mehigan DG, Bell WR, Zuidema GD, Eggleston JC, Cameron JL. Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg. 1980; 191(3):287-93.
15. Memsic L, Busuttil R, Traverso L. Bleeding esophageal varices and portal vein thrombosis after pancreatic mixed-cell auto-transplantation. Surgery. 1984;95(2):238-42.
16. Toledo-Pereyra L, Rowlett A, Cain W, Rosenberg J, Gordon D, MacKenzie G. Hepatic infarction following intraportal islet cell autotransplantation after near-total pancreatectomy. Transplan-tation. 1984;38(1):88-9.
17. Walsh T, Eggleston J, Cameron J. Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet auto-transplantation. Surgery. 1982;91(4):485-7.
18. Shapiro AMJ, Lakey J, Rajotte R, Warnock G, Friedlich M, Jewell L, et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/ islet allograft. Transplantation. 1995;59(7):1060-3.
19. Cameron J, Mehigan D, Broe P, Zuidema G. Distal pancreatec-tomy and islet autotransplantation for chronic pancreatitis. Ann Surg. 1981;193(3):312-7.
20. Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Källen R, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360(9350):2039-45.
21. Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A,etal. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islettransplantation. Diabetes. 2005;54(6):1755-62.
22. Kin T. Islet isolation for clinical transplantation. Adv Exp Med Biol. 2010;654:683-710.
23. Mosteller R. Simplified calculation ofbody-surface area. N Engl J Med. 1987;317(17):1098.
24. Willett W, Dietz W, Colditz G. Guidelines for healthy weight. N Engl J Med. 1999;341(6):427-34.
25. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, Liberase. Diabetes. 1997;46(7):1120-3.
26. Merani S, Toso C, Emamaullee J, Shapiro AMJ. Optimal implantation site for pancreatic islet transplantation. Br J Surg. 2008;95(12):1449-61.
27. Yin D, Ding JW, Shen J, Ma L, Hara M, Chong AS. Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant. 2006;6(1):60-8.
28. Villiger P, Ryan EA, Owen R, O'Kelly K, Oberholzer J, Saif FA, et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant. 2005;5(12):2992-8.
29. Hirshberg B, Rother KI, Digon BJ, Lee J, Gaglia JL, Hines K, et al. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression. Diabetes Care. 2003;26(12):3288-95.
30. Casey J, Lakey J, Ryan E, Paty B, Owen R, O'Kelly K, et al. Portal venous pressure changes after sequential clinical islet transplantation. Transplantation. 2002;74(7):913-5.
31. Gores P, Sutherland D. Pancreatic islet transplantation: is puri-fication necessary? Am J Surg. 1993;166(5):538-42.
32. Wahoff D, Papalois B, Najarian J, Kendall D, Farney A, Leone J, et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg. 1995;222(4):562-79.
33. Anazawa T, Balamurugan AN, Bellin M, Zhang HJ, Matsumoto S, Yonekawa Y, et al. Human islet isolation for autologous transplantation: comparison of yield and function using SERVA/ Nordmark versus Roche enzymes. Am J Transplant. 2009;9(10): 2383-91.